We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lombard Med.Tec | LSE:LMT | London | Ordinary Share | GB00B7FT8W85 | ORD 20P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 188.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
20/10/2010 19:24 | zzzzzzzzzzzzzzzzzzzz | webshares | |
19/10/2010 10:46 | Gone to sleep. | philo124 | |
11/10/2010 09:21 | If the broker thinks it is worth 3p,there must be other cash rich co's that see it too. It could all make for a very interesting next 12 months. We have fallen a long way from 150p! | restassured | |
11/10/2010 06:49 | i hope we don't have to wait 3 years before we see 1.59 i think the important points today are that Aorfix has CE approval (June 2009) and that gave sales in Europe an immediate boost. we saw that in the half year results with sales up 79% in Europe Aorfix is more likely than not within 12 months of FDA approval The Japanese deal secures another major market, an investment and cash injection Funds of nearly $12 million (after expenses) were raised in January at 1p I feel the 1p is important because it sets the low floor for fair value. The major shareholders that stumped up the cash, mainly Invesco, would not have done so without a firm belief that 1p was great value | nod | |
10/10/2010 22:46 | im waiting for 0.5p , did it years ago before they de listed , held the shares for about 3 years , then they relisted and i sold on the first day at 1.59 i made 5 times what i put in | sowingandgrowing | |
08/10/2010 16:42 | some of the medics involved with this are heavyweights in their field, and are presumably well-connected. | backmarker | |
08/10/2010 14:24 | Interesting point above.That tells me they could alway find a partner to stump up any cash if needed. | restassured | |
08/10/2010 10:18 | To recap the status and timing of the FDA approval which is in six modules. Three have been approved, two non-clinical modules are scheduled for this year and the final clinical module of the pre-market approval is planned for the first half of 2011. So we may be within 7 to 8 months of FDA approval. As we get closer and it becomes clear that LMT can raise funds to complete the FDA approval process, then the share price should adjust accordingly. At the minute there seems to be anxiety that LMT will not reach the end but I think this deal makes it very clear they will. Even without this deal the major shareholders would have stumped up the extra cash for the final leg of this long journey. | nod | |
08/10/2010 09:56 | buystock take a hike mate or you are going on filter for good - how many different names are you using? | moreforus | |
08/10/2010 09:54 | restassured - Evolution is LMT's nomad | nod | |
08/10/2010 09:29 | a takeover has to be a distinct possibility. i've added a few this a.m. to bring my total up to a derisory 100k. | backmarker | |
08/10/2010 08:39 | It seems to me that this co must be vulnerable to a takeover.The vast majority of the work has been done and approvals looks tantalisingly close. 150p to 1p is quite a fall! Any thoughts? | restassured | |
07/10/2010 18:53 | this would appear to resolve the funding issues through to post FDA approval, does it not ? so no more cash-raising ? that alone should be worth a few points on the share price the quality of Aorfix has never really been in doubt, just the company's ability to get it to FDA approval without spending vast sums of money. they failed on the latter, but hopefully the level of spend is now under control; and, with those vast sums spent now part of history, we can perhaps look forward to some good profits down the line. I had written off my much-diminished holding here, but at 1p it might just be worth spending £200 or so and doubling up :-) | backmarker | |
07/10/2010 18:15 | Regardless of Evolution target, history tells us that this should dip in the coming weeks & months and any big gains will only come on delivery of approval from FDA and Japan Regulatory Agency. The registration alone for a medical Device in Japan typically takes 6-12 months and the agency are meticulous about filings. Holding shares here a long time and have seen two listings and massive slides after both. I'll continue to hold but likelyhood of return is a small fraction of investment. Does anyone know any more information on the investment company? Could this investment be from Kirin Group (aka Kyowa)?? | roundyg | |
07/10/2010 13:20 | Company Rating Target Price Potential Upside/ Downside Contributing Broker Lombard Medical Technologies Buy 3 212.5% Evolution Securities | restassured | |
07/10/2010 12:24 | ok tvm | moreforus | |
07/10/2010 12:23 | No but it is real, 3p price target Evolution securities. | restassured | |
07/10/2010 10:43 | do you have a link? | moreforus | |
07/10/2010 10:43 | Thats good news! | philo124 | |
07/10/2010 10:39 | Evolution have stuck a 3p price target on these. | restassured | |
07/10/2010 08:06 | Long term play - this will likley drop back again in a few days - I'm holding, but this will not realise anything in the way of great gains until US FDA approval in late 2011 - don't get too excited :) | munkychunky | |
06/10/2010 16:23 | think it's a case of oh my gawd good news that will rerate this stock ive held for years.... quick everbody sell before the company gives us even better news !(-; | moreforus | |
06/10/2010 16:20 | Good volume, must be a seller still in the background. Long term play, should have known better no 'gold' in the title, dooh! | keya5000 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions